Medicine
STAT+: Pharmalittle: We’re reading about India’s new manufacturing rules, clinical trials in China, and more
India proposed rules requiring regulators to immediately suspend manufacturing licenses for drugs that fail quality standards in government testing
STAT+: Beyond statins, one drug lowered heart attack risk by 20%
A new study could help doctors figure out what medicine to prescribe for cholesterol when statins don't cut it: It's “answering a really challenging clinical question."
STAT+: Medicare delays controversial RPM rule update
Despite widespread opposition, Medicare will finalize a controversial proposal that will prevent providers, such as hospitals, from using third parties to deliver remote patient m…
‘Revenge of the nerds’: US midterms deliver a win for science – and a rebuke of Maha
The wins for Democrats come after years of cuts and upheaval to US health and science infrastructureA political organizations behind a wave of Democratic doctors and scientists wi…
Single-payer health care system proponents were thrown a big bone this election
Sen. Bernie Sanders is likely to lead the Senate’s health committee next year, which could grant him a chance to fundamentally alter how the FDA interacts with the companies it…
STAT+: Revolution Medicines’ pancreatic cancer drug has stunning commercial debut
Rasonque, Revolution Medicines' new pancreatic cancer drug, is off to one of the best oncology drug launches in history.
Teens worldwide aren't getting enough exercise -- especially girls
A new study looks at the recommended amount of daily exercise for adolescents — and how few are getting it.
Trump takes 500 actions to weaken cancer protections, new report says
Natural Resources Defense Council shows how federal rules changes will spike up public’s exposure to carcinogensAmid a surge in early onset cancer, the Trump administration has ta…
STAT+: A closer look at ProMis Neurosciences and its Alzheimer’s drug
Shares of ProMis Neurosciences, developer of a treatment for Alzheimer’s disease, sold off sharply last week. A closer look at the reason why — and whether it holds up.
Opinion: I’m a neurosurgeon. I’ve learned pain and suffering are very different things
“The cruelest response to suffering is to attempt to explain it away,” writes neurosurgeon Stephen Doran.
STAT+: In China, a flood of controversial clinical trials slows to a trickle
Following patient deaths, China restricts investigator-initiated biotech trials, leaving rare disease families and US investors facing an uncertain future.
STAT+: As more doctors consult chatbots, health systems can block them — or buy in
As hundreds of thousands of doctors consult AI chatbots to make care decisions, health systems see new risks to patients' health data.
STAT+: What the midterms could mean for the future of health AI
The midterms highlighted the negative sentiment around AI across the U.S. How will those attitudes trickle down to legislating AI use in health care?
Art is good for your health? Allow me a quick eyeroll | Emma Brockes
Some now suggest a monthly dose of art can boost wellbeing. But the last thing we need is another item on our to-do listsAs the long autumn subsides and we finally head into winte…
‘Ferritin face’: can you really diagnose low iron from a selfie? – podcast
Social media is awash with claims iron deficiency can be identified in the mirror by dark circles, breaking hair and dry skin. But is ‘ferritin face’ real? Madeleine Finlay tells …
Swapping from dairy to plant-based milk, cheese and yoghurt ‘could lead to micronutrient deficiencies’
Young people and women most at risk, study finds, as researchers call for vegan products to be fortified with iodine in particularSwitching from dairy products to plant-based alte…
STAT+: Pharma critic Bernie Sanders is set to hold major sway over FDA funding bill
Sanders could use his role in crafting the bill to push for reforms.
STAT+: Mass. marijuana consumers, workers high on victory after repeal of recreational weed sales fails in a rout
Massachusetts voters decisively shot down a ballot initiative that would have dismantled the state’s recreational cannabis industry.
STAT+: Democratic doctors and scientists ride the blue wave
The clinicians and researchers who will take office are ready to tackle the U.S. health care system.
British healthcare worker with Ebola evacuated from DR Congo to UK
Patient is in stable condition and will be transferred to a specialist ‘high consequence’ infectious disease unitA British healthcare worker with Ebola is being evacuated from t…
STAT+: Where does MAHA go from here? 3 possible futures
Republican losses leave Robert F. Kennedy Jr.’s MAHA movement with three possible futures.
STAT+: CVS Health to split, reversing years of deal-making to combine pharmacies and insurance
CVS Health’s decision to split comes amid federal and state scrutiny over vertical integration.
STAT+: A looming deadline to fund the government will shape Congress’ unusual lame duck session
Before Democrats take control, Congress must fund expiring health care programs, confirm HHS nominees
STAT+: Five midterm winners and losers: MAHA mowed down, Dem docs scrub in, Medicare for All returns
Democratic doctors were among the winners in the midterm elections, while the MAHA movement and President Trump's health agenda were losers.